spacer
spacer
Go to PDB code: 
protein metals links
Hydrolase PDB id
1a1q
Jmol
Contents
Protein chains
183 a.a.*
170 a.a.*
Metals
_ZN ×3
* C-alpha coords only
PDB id:
1a1q
Name: Hydrolase
Title: Hepatitis c virus ns3 proteinase
Structure: Ns3 proteinase. Chain: a, b, c. Engineered: yes
Source: Hepatitis c virus. Organism_taxid: 11103. Strain: type 1b. Variant: bk isolate. Gene: cdna. Expressed in: escherichia coli. Expression_system_taxid: 562. Isolated from pat. Other_details: expressed as soluble protein
Resolution:
2.40Å     R-factor:   0.225     R-free:   0.320
Authors: R.A.Love,H.E.Parge,J.A.Wickersham,Z.Hostomsky,N.Habuka, E.W.Moomaw,T.Adachi,Z.Hostomska
Key ref:
R.A.Love et al. (1996). The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell, 87, 331-342. PubMed id: 8861916 DOI: 10.1016/S0092-8674(00)81350-1
Date:
12-Dec-97     Release date:   25-Mar-98    
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P26663  (POLG_HCVBK) -  Genome polyprotein
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
3010 a.a.
183 a.a.*
Protein chain
Pfam   ArchSchema ?
P26663  (POLG_HCVBK) -  Genome polyprotein
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
3010 a.a.
170 a.a.*
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 8 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class 1: Chains A, B, C: E.C.2.7.7.48  - RNA-directed Rna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1)
Nucleoside triphosphate
+ RNA(n)
= diphosphate
+ RNA(n+1)
   Enzyme class 2: Chains A, B, C: E.C.3.4.21.98  - Hepacivirin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Hydrolysis of four peptide bonds in the viral precursor polyprotein, commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser or Ala in P1'.
   Enzyme class 3: Chains A, B, C: E.C.3.6.1.15  - Nucleoside-triphosphatase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: NTP + H2O = NDP + phosphate
NTP
+ H(2)O
= NDP
+ phosphate
   Enzyme class 4: Chains A, B, C: E.C.3.6.4.13  - Rna helicase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: ATP + H2O = ADP + phosphate
ATP
+ H(2)O
= ADP
+ phosphate
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site
 Gene Ontology (GO) functional annotation 
  GO annot!
  Biological process     transformation of host cell by virus   2 terms 
  Biochemical function     catalytic activity     2 terms  

 

 
    reference    
 
 
DOI no: 10.1016/S0092-8674(00)81350-1 Cell 87:331-342 (1996)
PubMed id: 8861916  
 
 
The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site.
R.A.Love, H.E.Parge, J.A.Wickersham, Z.Hostomsky, N.Habuka, E.W.Moomaw, T.Adachi, Z.Hostomska.
 
  ABSTRACT  
 
During replication of hepatitis C virus (HCV), the final steps of polyprotein processing are performed by a viral proteinase located in the N-terminal one-third of nonstructural protein 3. The structure of NS3 proteinase from HCV BK strain was determined by X-ray crystallography at 2.4 angstrom resolution. NS3P folds as a trypsin-like proteinase with two beta barrels and a catalytic triad of His-57, Asp-81, Ser-139. The structure has a substrate-binding site consistent with the cleavage specificity of the enzyme. Novel features include a structural zinc-binding site and a long N-terminus that interacts with neighboring molecules by binding to a hydrophobic surface patch.
 
  Selected figure(s)  
 
Figure 4.
Figure 4. Model of a Bound Polypeptide Substrate Containing the NS3/4A JunctionSide-by-side stereo view of the NS3/4A substrate (color-coded: green, C; red, O; blue, N) modeled into the active site of HCV NS3P, which is covered by a molecular surface in white dots (generated by the MS program[12] using a 1.6 Šprobe radius). The Cα trace of NS3P is shown in yellow, with the oxyanion-stabilizing loop in purple and the extended strand βE2 in red. NS3P side chains (color-coded: yellow, C; red, O; blue, N) are shown for residues comprising the S1 specificity pocket (L135, F154, A157), the potential P6 recognition elements (R161, K165), and active-site serine (S139). The substrate is labeled according to the standard P/P' convention, while the HCV residues are labeled in the single-letter amino acid code.
Figure 5.
Figure 5. Solvent-Accessible Surface of NS3P Monomer 1, Colored by Hydrophobicity, Such That Nonpolar Residues Are White, Charged Residues Are Deep Magenta, and Polar Residues Are Medium Shades of MagentaThe central white region is the hydrophobic patch (approximately 400 Å^2) discussed in the text. In the crystal, there are two N-terminal strands from neighboring molecules bound to this patch, namely βC0 from monomer 3 (blue ribbon) and βA0 from monomer 1' (green ribbon). Strand βC0 buries Cys-16 and Ile-18, while strand βA0 buries Ile-3 and Ala-5, into the center of the hydrophobic surface patch. Residues Ser-20 of βC0 and Ser-7 of βA0 lie at the edge of the interface and hydrogen-bond to monomer 1. Also shown in yellow (at bottom horizon of surface) is the P3′ residue of a modeled substrate polypeptide (see Figure 4), included here as a directional reference to the active site.
 
  The above figures are reprinted by permission from Cell Press: Cell (1996, 87, 331-342) copyright 1996.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20863235 B.Lee, K.B.Kim, S.Oh, J.S.Choi, J.S.Park, D.H.Min, and D.E.Kim (2010).
Suppression of hepatitis C virus genome replication in cells with RNA-cleaving DNA enzymes and short-hairpin RNA.
  Oligonucleotides, 20, 285-296.  
20345213 N.Bostan, and T.Mahmood (2010).
An overview about hepatitis C: a devastating virus.
  Crit Rev Microbiol, 36, 91.  
21105106 Z.Zhu, A.T.Wilson, B.A.Luxon, K.E.Brown, M.M.Mathahs, S.Bandyopadhyay, A.P.McCaffrey, and W.N.Schmidt (2010).
Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: Mechanism for the antiviral effects of heme oxygenase?
  Hepatology, 52, 1897-1905.  
19183149 A.J.Thompson, and J.G.McHutchison (2009).
Review article: investigational agents for chronic hepatitis C.
  Aliment Pharmacol Ther, 29, 689-705.  
19515018 H.Tang, and H.Grisé (2009).
Cellular and molecular biology of HCV infection and hepatitis.
  Clin Sci (Lond), 117, 49-65.  
19515772 T.Phan, R.K.Beran, C.Peters, I.C.Lorenz, and B.D.Lindenbach (2009).
Hepatitis C virus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes.
  J Virol, 83, 8379-8395.  
19344246 V.Meier, and G.Ramadori (2009).
Hepatitis C virus virology and new treatment targets.
  Expert Rev Anti Infect Ther, 7, 329-350.  
19282477 V.Schregel, S.Jacobi, F.Penin, and N.Tautz (2009).
Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3.
  Proc Natl Acad Sci U S A, 106, 5342-5347.  
18799730 V.Brass, J.M.Berke, R.Montserret, H.E.Blum, F.Penin, and D.Moradpour (2008).
Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex.
  Proc Natl Acad Sci U S A, 105, 14545-14550.  
17289677 C.L.Johnson, D.M.Owen, and M.Gale (2007).
Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
  J Biol Chem, 282, 10792-10803.  
17094110 C.Oliva, A.Rodríguez, M.González, and W.Yang (2007).
A quantum mechanics/molecular mechanics study of the reaction mechanism of the hepatitis C virus NS3 protease with the NS5A/5B substrate.
  Proteins, 66, 444-455.  
17484890 J.M.Pawlotsky, S.Chevaliez, and J.G.McHutchison (2007).
The hepatitis C virus life cycle as a target for new antiviral therapies.
  Gastroenterology, 132, 1979-1998.  
17554050 K.L.Maxwell, and L.Frappier (2007).
Viral proteomics.
  Microbiol Mol Biol Rev, 71, 398-411.  
17335672 M.S.Sulkowski (2007).
Specific targeted antiviral therapy for hepatitis C.
  Curr Gastroenterol Rep, 9, 5.  
17869377 R.De Francesco, and A.Carfí (2007).
Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus.
  Adv Drug Deliv Rev, 59, 1242-1262.  
17509079 S.Melino, and M.Paci (2007).
Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
  FEBS J, 274, 2986-3002.  
17522203 T.L.Tellinghuisen, M.J.Evans, T.von Hahn, S.You, and C.M.Rice (2007).
Studying hepatitis C virus: making the best of a bad virus.
  J Virol, 81, 8853-8867.  
17825945 T.Suzuki, K.Ishii, H.Aizaki, and T.Wakita (2007).
Hepatitis C viral life cycle.
  Adv Drug Deliv Rev, 59, 1200-1212.  
16495264 B.A.Malcolm, R.Liu, F.Lahser, S.Agrawal, B.Belanger, N.Butkiewicz, R.Chase, F.Gheyas, A.Hart, D.Hesk, P.Ingravallo, C.Jiang, R.Kong, J.Lu, J.Pichardo, A.Prongay, A.Skelton, X.Tong, S.Venkatraman, E.Xia, V.Girijavallabhan, and F.G.Njoroge (2006).
SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells.
  Antimicrob Agents Chemother, 50, 1013-1020.  
16862121 I.C.Lorenz, J.Marcotrigiano, T.G.Dentzer, and C.M.Rice (2006).
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease.
  Nature, 442, 831-835.
PDB code: 2hd0
17048113 M.Moriyama, H.Matsumura, A.Fukushima, K.Ohkido, Y.Arakawa, K.Nirei, H.Yamagami, M.Kaneko, N.Tanaka, and Y.Arakawa (2006).
Clinical significance of evaluation of serum zinc concentrations in C-viral chronic liver disease.
  Dig Dis Sci, 51, 1967-1977.  
16407182 N.Appel, T.Schaller, F.Penin, and R.Bartenschlager (2006).
From structure to function: new insights into hepatitis C virus RNA replication.
  J Biol Chem, 281, 9833-9836.  
16532006 P.Erbel, N.Schiering, A.D'Arcy, M.Renatus, M.Kroemer, S.P.Lim, Z.Yin, T.H.Keller, S.G.Vasudevan, and U.Hommel (2006).
Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
  Nat Struct Mol Biol, 13, 372-373.
PDB codes: 2fom 2fp7
15994762 C.Zhang, Z.Cai, Y.C.Kim, R.Kumar, F.Yuan, P.Y.Shi, C.Kao, and G.Luo (2005).
Stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymerase.
  J Virol, 79, 8687-8697.  
16408072 H.Sakamoto, K.Okamoto, M.Aoki, H.Kato, A.Katsume, A.Ohta, T.Tsukuda, N.Shimma, Y.Aoki, M.Arisawa, M.Kohara, and M.Sudoh (2005).
Host sphingolipid biosynthesis as a target for hepatitis C virus therapy.
  Nat Chem Biol, 1, 333-337.  
15767257 J.C.Ferreon, A.C.Ferreon, K.Li, and S.M.Lemon (2005).
Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease.
  J Biol Chem, 280, 20483-20492.  
16308536 K.Watashi, and K.Shimotohno (2005).
[Current approaches for developing new anti-HCV agents and analyses of HCV replication using anti-HCV agents]
  Uirusu, 55, 105-110.  
16107835 R.De Francesco, and G.Migliaccio (2005).
Challenges and successes in developing new therapies for hepatitis C.
  Nature, 436, 953-960.  
15681139 U.C.Chaturvedi, and R.Shrivastava (2005).
Interaction of viral proteins with metal ions: role in maintaining the structure and functions of viruses.
  FEMS Immunol Med Microbiol, 43, 105-114.  
16301520 X.D.Li, L.Sun, R.B.Seth, G.Pineda, and Z.J.Chen (2005).
Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.
  Proc Natl Acad Sci U S A, 102, 17717-17722.  
14766754 C.Lin, K.Lin, Y.P.Luong, B.G.Rao, Y.Y.Wei, D.L.Brennan, J.R.Fulghum, H.M.Hsiao, S.Ma, J.P.Maxwell, K.M.Cottrell, R.B.Perni, C.A.Gates, and A.D.Kwong (2004).
In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms.
  J Biol Chem, 279, 17508-17514.  
14752815 F.Penin, J.Dubuisson, F.A.Rey, D.Moradpour, and J.M.Pawlotsky (2004).
Structural biology of hepatitis C virus.
  Hepatology, 39, 5.  
15521004 H.Hinrichsen, Y.Benhamou, H.Wedemeyer, M.Reiser, R.E.Sentjens, J.L.Calleja, X.Forns, A.Erhardt, J.Crönlein, R.L.Chaves, C.L.Yong, G.Nehmiz, and G.G.Steinmann (2004).
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.
  Gastroenterology, 127, 1347-1355.  
14768012 J.M.Pawlotsky, and J.G.McHutchison (2004).
Hepatitis C. Development of new drugs and clinical trials: promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27-March 1, 2003.
  Hepatology, 39, 554-567.  
15521029 J.M.Pawlotsky (2004).
Hepatitis C: it's a long way to new therapy, it's a long way to go...
  Gastroenterology, 127, 1629-1632.  
15048818 M.Shokhen, and A.Albeck (2004).
Identification of protons position in acid-base enzyme catalyzed reactions: the hepatitis C viral NS3 protease.
  Proteins, 55, 245-250.  
15564480 P.Niyomrattanakit, P.Winoyanuwattikun, S.Chanprapaph, C.Angsuthanasombat, S.Panyim, and G.Katzenmeier (2004).
Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.
  J Virol, 78, 13708-13716.  
15367643 T.Lackner, A.Müller, A.Pankraz, P.Becher, H.J.Thiel, A.E.Gorbalenya, and N.Tautz (2004).
Temporal modulation of an autoprotease is crucial for replication and pathogenicity of an RNA virus.
  J Virol, 78, 10765-10775.  
15268625 V.Brass, H.E.Blum, and D.Moradpour (2004).
Recent developments in target identification against hepatitis C virus.
  Expert Opin Ther Targets, 8, 295-307.  
14694101 W.Wang, F.C.Lahser, M.Yi, J.Wright-Minogue, E.Xia, P.C.Weber, S.M.Lemon, and B.A.Malcolm (2004).
Conserved C-terminal threonine of hepatitis C virus NS3 regulates autoproteolysis and prevents product inhibition.
  J Virol, 78, 700-709.  
15386268 Y.S.Tsantrizos (2004).
The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.
  Biopolymers, 76, 309-323.  
12646587 A.Pause, G.Kukolj, M.Bailey, M.Brault, F.Dô, T.Halmos, L.Lagacé, R.Maurice, M.Marquis, G.McKercher, C.Pellerin, L.Pilote, D.Thibeault, and D.Lamarre (2003).
An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA.
  J Biol Chem, 278, 20374-20380.  
12610142 C.Trozzi, L.Bartholomew, A.Ceccacci, G.Biasiol, L.Pacini, S.Altamura, F.Narjes, E.Muraglia, G.Paonessa, U.Koch, R.De Francesco, C.Steinkuhler, and G.Migliaccio (2003).
In vitro selection and characterization of hepatitis C virus serine protease variants resistant to an active-site peptide inhibitor.
  J Virol, 77, 3669-3679.  
  12556211 F.Narjes, U.Koch, and C.Steinkühler (2003).
Recent developments in the discovery of hepatitis C virus serine protease inhibitors--towards a new class of antiviral agents?
  Expert Opin Investig Drugs, 12, 153-163.  
12917405 L.Vasiljeva, A.Merits, A.Golubtsov, V.Sizemskaja, L.Kääriäinen, and T.Ahola (2003).
Regulation of the sequential processing of Semliki Forest virus replicase polyprotein.
  J Biol Chem, 278, 41636-41645.  
12882616 M.P.Walker, N.Yao, and Z.Hong (2003).
Promising candidates for the treatment of chronic hepatitis C.
  Expert Opin Investig Drugs, 12, 1269-1280.  
12509436 M.Wang, K.K.Ng, M.M.Cherney, L.Chan, C.G.Yannopoulos, J.Bedard, N.Morin, N.Nguyen-Ba, M.H.Alaoui-Ismaili, R.C.Bethell, and M.N.James (2003).
Non-nucleoside analogue inhibitors bind to an allosteric site on HCV NS5B polymerase. Crystal structures and mechanism of inhibition.
  J Biol Chem, 278, 9489-9495.
PDB codes: 1nhu 1nhv
12843009 S.Ogata, R.H.Florese, M.Nagano-Fujii, R.Hidajat, L.Deng, Y.Ku, S.Yoon, T.Saito, S.Kawata, and H.Hotta (2003).
Identification of hepatitis C virus (HCV) subtype 1b strains that are highly, or only weakly, associated with hepatocellular carcinoma on the basis of the secondary structure of an amino-terminal portion of the HCV NS3 protein.
  J Clin Microbiol, 41, 2835-2841.  
12192066 A.Casbarra, F.D.Piaz, P.Ingallinella, S.Orrù, P.Pucci, A.Pessi, and E.Bianchi (2002).
The effect of prime-site occupancy on the hepatitis C virus NS3 protease structure.
  Protein Sci, 11, 2102-2112.  
12325160 E.Bianchi, and A.Pessi (2002).
Inhibiting viral proteases: challenges and opportunities.
  Biopolymers, 66, 101-114.  
11969409 P.Ingallinella, D.Fattori, S.Altamura, C.Steinkühler, U.Koch, D.Cicero, R.Bazzo, R.Cortese, E.Bianchi, and A.Pessi (2002).
Prime site binding inhibitors of a serine protease: NS3/4A of hepatitis C virus.
  Biochemistry, 41, 5483-5492.  
11867545 P.S.Pang, E.Jankowsky, P.J.Planet, and A.M.Pyle (2002).
The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding.
  EMBO J, 21, 1168-1176.  
  11841941 S.J.Archer, D.M.Camac, Z.J.Wu, N.A.Farrow, P.J.Domaille, Z.R.Wasserman, M.Bukhtiyarova, C.Rizzo, S.Jagannathan, L.J.Mersinger, and C.A.Kettner (2002).
Hepatitis C virus NS3 protease requires its NS4A cofactor peptide for optimal binding of a boronic acid inhibitor as shown by NMR.
  Chem Biol, 9, 79-92.  
11245202 A.Pessi (2001).
A personal account of the role of peptide research in drug discovery: the case of hepatitis C.
  J Pept Sci, 7, 2.  
15989494 B.W.Dymock (2001).
Emerging therapies for hepatitis C virus infection.
  Expert Opin Emerg Drugs, 6, 13-42.  
11260254 K.Hara, M.Shiota, H.Kido, Y.Ohtsu, T.Kashiwagi, J.Iwahashi, N.Hamada, K.Mizoue, N.Tsumura, H.Kato, and T.Toyoda (2001).
Influenza virus RNA polymerase PA subunit is a novel serine protease with Ser624 at the active site.
  Genes Cells, 6, 87-97.  
11238848 P.Borowski, A.Niebuhr, O.Mueller, M.Bretner, K.Felczak, T.Kulikowski, and H.Schmitz (2001).
Purification and characterization of West Nile virus nucleoside triphosphatase (NTPase)/helicase: evidence for dissociation of the NTPase and helicase activities of the enzyme.
  J Virol, 75, 3220-3229.  
11160669 R.Banerjee, and A.Dasgupta (2001).
Specific interaction of hepatitis C virus protease/helicase NS3 with the 3'-terminal sequences of viral positive- and negative-strand RNA.
  J Virol, 75, 1708-1721.  
11745930 T.Heintges, J.Encke, J.zu Putlitz, and J.R.Wands (2001).
Inhibition of hepatitis C virus NS3 function by antisense oligodeoxynucleotides and protease inhibitor.
  J Med Virol, 65, 671-680.  
11206478 W.T.Sing, C.L.Lee, S.L.Yeo, S.P.Lim, and M.M.Sim (2001).
Arylalkylidene rhodanine with bulky and hydrophobic functional group as selective HCV NS3 protease inhibitor.
  Bioorg Med Chem Lett, 11, 91-94.  
11119590 Y.L.Khu, E.Koh, S.P.Lim, Y.H.Tan, S.Brenner, S.G.Lim, W.J.Hong, and P.Y.Goh (2001).
Mutations that affect dimer formation and helicase activity of the hepatitis C virus helicase.
  J Virol, 75, 205-214.  
10933699 A.Kanjanahaluethai, and S.C.Baker (2000).
Identification of mouse hepatitis virus papain-like proteinase 2 activity.
  J Virol, 74, 7911-7921.  
10666260 B.Wölk, D.Sansonno, H.G.Kräusslich, F.Dammacco, C.M.Rice, H.E.Blum, and D.Moradpour (2000).
Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines.
  J Virol, 74, 2293-2304.  
10809747 D.Fattori, A.Urbani, M.Brunetti, R.Ingenito, A.Pessi, K.Prendergast, F.Narjes, V.G.Matassa, R.De Francesco, and C.Steinkühler (2000).
Probing the active site of the hepatitis C virus serine protease by fluorescence resonance energy transfer.
  J Biol Chem, 275, 15106-15113.  
11068074 F.López-Jiménez, M.Brito, Y.W.Aude, P.Scheinberg, M.Kaplan, D.A.Dixon, N.Schneiderman, J.F.Trejo, L.H.López-Salazar, E.J.Ramírez-Barba, R.Kalil, C.Ortiz, J.Goyos, A.Buenaño, S.Kottiech, and G.A.Lamas (2000).
Update in internal medicine.
  Arch Med Res, 31, 329-352.  
10716920 G.Barbato, D.O.Cicero, F.Cordier, F.Narjes, B.Gerlach, S.Sambucini, S.Grzesiek, V.G.Matassa, R.De Francesco, and R.Bazzo (2000).
Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain.
  EMBO J, 19, 1195-1206.
PDB code: 1dxw
10924011 J.Encke, and J.R.Wands (2000).
Ethanol inhibition: the humoral and cellular immune response to hepatitis C virus NS5 protein after genetic immunization.
  Alcohol Clin Exp Res, 24, 1063-1069.  
10848986 K.Fukuda, D.Vishnuvardhan, S.Sekiya, J.Hwang, N.Kakiuchi, K.Taira, K.Shimotohno, P.K.Kumar, and S.Nishikawa (2000).
Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease.
  Eur J Biochem, 267, 3685-3694.  
11044100 L.Pacini, A.Vitelli, G.Filocamo, L.Bartholomew, M.Brunetti, A.Tramontano, C.Steinkühler, and G.Migliaccio (2000).
In vivo selection of protease cleavage sites by using chimeric Sindbis virus libraries.
  J Virol, 74, 10563-10570.  
10756044 N.Butkiewicz, N.Yao, W.Zhong, J.Wright-Minogue, P.Ingravallo, R.Zhang, J.Durkin, D.N.Standring, B.M.Baroudy, D.V.Sangar, S.M.Lemon, J.Y.Lau, and Z.Hong (2000).
Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
  J Virol, 74, 4291-4301.  
  11252351 N.Kato (2000).
Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation.
  Microb Comp Genomics, 5, 129-151.  
10702283 S.Di Marco, M.Rizzi, C.Volpari, M.A.Walsh, F.Narjes, S.Colarusso, R.De Francesco, V.G.Matassa, and M.Sollazzo (2000).
Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes.
  J Biol Chem, 275, 7152-7157.
PDB codes: 1dxp 1dy8 1dy9
10864639 T.Ueno, S.Misawa, Y.Ohba, M.Matsumoto, M.Mizunuma, N.Kasai, K.Tsumoto, I.Kumagai, and H.Hayashi (2000).
Isolation and characterization of monoclonal antibodies that inhibit hepatitis C virus NS3 protease.
  J Virol, 74, 6300-6308.  
  9882374 E.Ferrari, J.Wright-Minogue, J.W.Fang, B.M.Baroudy, J.Y.Lau, and Z.Hong (1999).
Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli.
  J Virol, 73, 1649-1654.  
  9847361 G.Filocamo, L.Pacini, C.Nardi, L.Bartholomew, M.Scaturro, P.Delmastro, A.Tramontano, R.De Francesco, and G.Migliaccio (1999).
Selection of functional variants of the NS3-NS4A protease of hepatitis C virus by using chimeric sindbis viruses.
  J Virol, 73, 561-575.  
  10574802 H.Ago, T.Adachi, A.Yoshida, M.Yamamoto, N.Habuka, K.Yatsunami, and M.Miyano (1999).
Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus.
  Structure, 7, 1417-1426.
PDB code: 1quv
10026173 H.M.Murthy, S.Clum, and R.Padmanabhan (1999).
Dengue virus NS3 serine protease. Crystal structure and insights into interaction of the active site with substrates by molecular modeling and structural analysis of mutational effects.
  J Biol Chem, 274, 5573-5580.
PDB code: 1bef
10611646 J.D.Tyndall, and D.P.Fairlie (1999).
Conformational homogeneity in molecular recognition by proteolytic enzymes.
  J Mol Recognit, 12, 363-370.  
10523291 J.F.Petersen, M.M.Cherney, H.D.Liebig, T.Skern, E.Kuechler, and M.N.James (1999).
The structure of the 2A proteinase from a common cold virus: a proteinase responsible for the shut-off of host-cell protein synthesis.
  EMBO J, 18, 5463-5475.
PDB code: 2hrv
10329692 J.Herold, S.G.Siddell, and A.E.Gorbalenya (1999).
A human RNA viral cysteine proteinase that depends upon a unique Zn2+-binding finger connecting the two domains of a papain-like fold .
  J Biol Chem, 274, 14918-14925.  
  10574797 N.Yao, P.Reichert, S.S.Taremi, W.W.Prosise, and P.C.Weber (1999).
Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase.
  Structure, 7, 1353-1363.
PDB code: 1cu1
10574908 P.L.Darke, A.R.Jacobs, L.Waxman, and L.C.Kuo (1999).
Inhibition of hepatitis C virus NS2/3 processing by NS4A peptides. Implications for control of viral processing.
  J Biol Chem, 274, 34511-34514.  
  10422832 S.Orrù, F.Dal Piaz, A.Casbarra, G.Biasiol, R.De Francesco, C.Steinkühler, and P.Pucci (1999).
Conformational changes in the NS3 protease from hepatitis C virus strain Bk monitored by limited proteolysis and mass spectrometry.
  Protein Sci, 8, 1445-1454.  
10373473 S.R.LaPlante, D.R.Cameron, N.Aubry, S.Lefebvre, G.Kukolj, R.Maurice, D.Thibeault, D.Lamarre, and M.Llinàs-Brunet (1999).
Solution structure of substrate-based ligands when bound to hepatitis C virus NS3 protease domain.
  J Biol Chem, 274, 18618-18624.  
9857201 A.Guarné, J.Tormo, R.Kirchweger, D.Pfistermueller, I.Fita, and T.Skern (1998).
Structure of the foot-and-mouth disease virus leader protease: a papain-like fold adapted for self-processing and eIF4G recognition.
  EMBO J, 17, 7469-7479.
PDB code: 1qol
  9767059 A.K.Patick, and K.E.Potts (1998).
Protease inhibitors as antiviral agents.
  Clin Microbiol Rev, 11, 614-627.  
  9420302 A.S.Belyaev, S.Chong, A.Novikov, A.Kongpachith, F.R.Masiarz, M.Lim, and J.P.Kim (1998).
Hepatitis G virus encodes protease activities which can effect processing of the virus putative nonstructural proteins.
  J Virol, 72, 868-872.  
9668049 A.Urbani, R.Bazzo, M.C.Nardi, D.O.Cicero, R.De Francesco, C.Steinkühler, and G.Barbato (1998).
The metal binding site of the hepatitis C virus NS3 protease. A spectroscopic investigation.
  J Biol Chem, 273, 18760-18769.  
9845474 B.Duffy, C.Schwietert, A.France, N.Mann, K.Culbertson, B.Harmon, and J.P.McCue (1998).
Transition metals as protease inhibitors.
  Biol Trace Elem Res, 64, 197-213.  
9657112 D.Moradpour, P.Kary, C.M.Rice, and H.E.Blum (1998).
Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins.
  Hepatology, 28, 192-201.  
9761831 L.W.Kang, H.S.Cho, S.S.Cha, K.M.Chung, S.H.Back, S.K.Jang, and B.H.Oh (1998).
Crystallization and preliminary X-ray crystallographic analysis of the helicase domain of hepatitis C virus NS3 protein.
  Acta Crystallogr D Biol Crystallogr, 54, 121-123.  
9873610 M.Llinàs-Brunet, M.Bailey, R.Déziel, G.Fazal, V.Gorys, S.Goulet, T.Halmos, R.Maurice, M.Poirier, M.A.Poupart, J.Rancourt, D.Thibeault, D.Wernic, and D.Lamarre (1998).
Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease.
  Bioorg Med Chem Lett, 8, 2719-2724.  
  9658124 P.Gallinari, D.Brennan, C.Nardi, M.Brunetti, L.Tomei, C.Steinkühler, and R.De Francesco (1998).
Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus.
  J Virol, 72, 6758-6769.  
  9420267 R.P.Valle, and B.Falgout (1998).
Mutagenesis of the NS3 protease of dengue virus type 2.
  J Virol, 72, 624-632.  
  9792101 S.S.Taremi, B.Beyer, M.Maher, N.Yao, W.Prosise, P.C.Weber, and B.A.Malcolm (1998).
Construction, expression, and characterization of a novel fully activated recombinant single-chain hepatitis C virus protease.
  Protein Sci, 7, 2143-2149.  
9581498 Z.Wu, N.Yao, H.V.Le, and P.C.Weber (1998).
Mechanism of autoproteolysis at the NS2-NS3 junction of the hepatitis C virus polyprotein.
  Trends Biochem Sci, 23, 92-94.  
  9261364 C.Lin, J.W.Wu, K.Hsiao, and M.S.Su (1997).
The hepatitis C virus NS4A protein: interactions with the NS4B and NS5A proteins.
  J Virol, 71, 6465-6471.  
  9188562 E.Scarselli, A.Urbani, A.Sbardellati, L.Tomei, R.De Francesco, and C.Traboni (1997).
GB virus B and hepatitis C virus NS3 serine proteases share substrate specificity.
  J Virol, 71, 4985-4989.  
  9223530 G.M.Heilek, and M.G.Peterson (1997).
A point mutation abolishes the helicase but not the nucleoside triphosphatase activity of hepatitis C virus NS3 protein.
  J Virol, 71, 6264-6266.  
  9188600 J.Xu, E.Mendez, P.R.Caron, C.Lin, M.A.Murcko, M.S.Collett, and C.M.Rice (1997).
Bovine viral diarrhea virus NS3 serine proteinase: polyprotein cleavage sites, cofactor requirements, and molecular model of an enzyme essential for pestivirus replication.
  J Virol, 71, 5312-5322.  
  9261354 L.Pieroni, E.Santolini, C.Fipaldini, L.Pacini, G.Migliaccio, and N.La Monica (1997).
In vitro study of the NS2-3 protease of hepatitis C virus.
  J Virol, 71, 6373-6380.  
  9060645 M.Stempniak, Z.Hostomska, B.R.Nodes, and Z.Hostomsky (1997).
The NS3 proteinase domain of hepatitis C virus is a zinc-containing enzyme.
  J Virol, 71, 2881-2886.  
  9311825 N.Dimasi, F.Martin, C.Volpari, M.Brunetti, G.Biasiol, S.Altamura, R.Cortese, R.De Francesco, C.Steinkühler, and M.Sollazzo (1997).
Characterization of engineered hepatitis C virus NS3 protease inhibitors affinity selected from human pancreatic secretory trypsin inhibitor and minibody repertoires.
  J Virol, 71, 7461-7469.  
  9188613 N.Tautz, K.Elbers, D.Stoll, G.Meyers, and H.J.Thiel (1997).
Serine protease of pestiviruses: determination of cleavage sites.
  J Virol, 71, 5415-5422.  
9187654 N.Yao, T.Hesson, M.Cable, Z.Hong, A.D.Kwong, H.V.Le, and P.C.Weber (1997).
Structure of the hepatitis C virus RNA helicase domain.
  Nat Struct Biol, 4, 463-467.
PDB code: 1hei
  9223519 R.Zhang, J.Durkin, W.T.Windsor, C.McNemar, L.Ramanathan, and H.V.Le (1997).
Probing the substrate specificity of hepatitis C virus NS3 serine protease by using synthetic peptides.
  J Virol, 71, 6208-6213.  
  9188558 S.Muramatsu, S.Ishido, T.Fujita, M.Itoh, and H.Hotta (1997).
Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization.
  J Virol, 71, 4954-4961.  
  9224923 S.Spada, C.Krebber, and A.Plückthun (1997).
Selectively infective phages (SIP).
  Biol Chem, 378, 445-456.  
  9343198 V.Lohmann, F.Körner, U.Herian, and R.Bartenschlager (1997).
Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity.
  J Virol, 71, 8416-8428.  
9357315 W.F.Mangel, D.L.Toledo, J.Ding, R.M.Sweet, and W.J.McGrath (1997).
Temporal and spatial control of the adenovirus proteinase by both a peptide and the viral DNA.
  Trends Biochem Sci, 22, 393-398.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.